Research project

Research project:

• Synthesis, labeling, and evaluation of organic molecules serving as radioligands for the CCK-2 receptor
• Molecular imaging of inflammatory processes and neoplasms using radiolabeled probes targeting anti-miRNA
• Monoclonal antibodies radiolabeled with Zirconium-89 for immuno-PET
• Study of new chelators for predominantly soft metallic radionuclides
• Development of new labeling methods involving the 18Fluoro-Metal bond
• Production, purification, and incorporation into molecular structures of the theranostic radionuclide silver-111.
• Study of the influence of dietary regimens on the uptake of the radiopharmaceutical 18F-FDG
• Synthesis, labeling, and evaluation of radiolabeled inhibitors of Mono-Carboxylate Transporters
• Study of new chelators for the gallium-68 radionuclide derived from the structure of rigidified HBED.
• Study of innovative linear or cyclic chelators for the theranostic radionuclide lutetium-177
• Evaluation of new entities for complexing the radionuclide Ra-223 for alpha-target therapy
• CRP F-22078 "Development of Potential Lutetium-177 Radiopharmaceuticals: Design, Radiolabeling, and Nonclinical Evaluation"
• A phase III multi-center, randomized, open-label study to evaluate the efficacy and safety of Lutathera in patients with Grade 2 and Grade 3 advanced GEP-NET (EUDRACT: 2019-001562-15) P.I. Dr. A. Versari